Cargando…

A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks

BACKGROUND: Disclosure of potential conflicts of interest (CoI) is a standard practice for many biomedical journals but not for educational materials. The goal of this investigation was to determine whether the authors of pharmacology textbooks have undisclosed financial CoIs and to identify author...

Descripción completa

Detalles Bibliográficos
Autores principales: Piper, Brian J., Telku, Hassenet M., Lambert, Drew A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516247/
https://www.ncbi.nlm.nih.gov/pubmed/26214515
http://dx.doi.org/10.1371/journal.pone.0133261
_version_ 1782383035714371584
author Piper, Brian J.
Telku, Hassenet M.
Lambert, Drew A.
author_facet Piper, Brian J.
Telku, Hassenet M.
Lambert, Drew A.
author_sort Piper, Brian J.
collection PubMed
description BACKGROUND: Disclosure of potential conflicts of interest (CoI) is a standard practice for many biomedical journals but not for educational materials. The goal of this investigation was to determine whether the authors of pharmacology textbooks have undisclosed financial CoIs and to identify author characteristics associated with CoIs. METHODS AND FINDINGS: The presence of potential CoIs was evaluated by submitting author names (N = 403; 36.3% female) to a patent database (Google Scholar) as well as a database that reports on the compensation ($USD) received from 15 pharmaceutical companies (ProPublica’s Dollars for Docs). All publications (N = 410) of the ten highest compensated authors from 2009 to 2013 and indexed in Pubmed were also examined for disclosure of additional companies that the authors received research support, consulted, or served on speaker’s bureaus. A total of 134 patents had been awarded (Maximum = 18/author) to textbook authors. Relative to DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, contributors to Goodman and Gilman’s Pharmacological Basis of Therapeutics and Katzung’s Basic and Clinical Pharmacology were more frequently patent holders (OR = 6.45, P < .0005). Female authors were less likely than males to have > 1 patent (OR = 0.15, P < .0005). A total of $2,411,080 USD (28.3% for speaking, 27.0% for consulting, and 23.9% for research), was received by 53 authors (Range = $299 to $310,000/author). Highly compensated authors were from multiple fields including oncology, psychiatry, neurology, and urology. The maximum number of additional companies, not currently indexed in the Dollars for Docs database, for which an author had potential CoIs was 73. CONCLUSIONS: Financial CoIs are common among the authors of pharmacology and pharmacotherapy textbooks. Full transparency of potential CoIs, particularly patents, should become standard procedure for future editions of educational materials in pharmacology.
format Online
Article
Text
id pubmed-4516247
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-45162472015-07-29 A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks Piper, Brian J. Telku, Hassenet M. Lambert, Drew A. PLoS One Research Article BACKGROUND: Disclosure of potential conflicts of interest (CoI) is a standard practice for many biomedical journals but not for educational materials. The goal of this investigation was to determine whether the authors of pharmacology textbooks have undisclosed financial CoIs and to identify author characteristics associated with CoIs. METHODS AND FINDINGS: The presence of potential CoIs was evaluated by submitting author names (N = 403; 36.3% female) to a patent database (Google Scholar) as well as a database that reports on the compensation ($USD) received from 15 pharmaceutical companies (ProPublica’s Dollars for Docs). All publications (N = 410) of the ten highest compensated authors from 2009 to 2013 and indexed in Pubmed were also examined for disclosure of additional companies that the authors received research support, consulted, or served on speaker’s bureaus. A total of 134 patents had been awarded (Maximum = 18/author) to textbook authors. Relative to DiPiro’s Pharmacotherapy: A Pathophysiologic Approach, contributors to Goodman and Gilman’s Pharmacological Basis of Therapeutics and Katzung’s Basic and Clinical Pharmacology were more frequently patent holders (OR = 6.45, P < .0005). Female authors were less likely than males to have > 1 patent (OR = 0.15, P < .0005). A total of $2,411,080 USD (28.3% for speaking, 27.0% for consulting, and 23.9% for research), was received by 53 authors (Range = $299 to $310,000/author). Highly compensated authors were from multiple fields including oncology, psychiatry, neurology, and urology. The maximum number of additional companies, not currently indexed in the Dollars for Docs database, for which an author had potential CoIs was 73. CONCLUSIONS: Financial CoIs are common among the authors of pharmacology and pharmacotherapy textbooks. Full transparency of potential CoIs, particularly patents, should become standard procedure for future editions of educational materials in pharmacology. Public Library of Science 2015-07-27 /pmc/articles/PMC4516247/ /pubmed/26214515 http://dx.doi.org/10.1371/journal.pone.0133261 Text en © 2015 Piper et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Piper, Brian J.
Telku, Hassenet M.
Lambert, Drew A.
A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title_full A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title_fullStr A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title_full_unstemmed A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title_short A Quantitative Analysis of Undisclosed Conflicts of Interest in Pharmacology Textbooks
title_sort quantitative analysis of undisclosed conflicts of interest in pharmacology textbooks
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516247/
https://www.ncbi.nlm.nih.gov/pubmed/26214515
http://dx.doi.org/10.1371/journal.pone.0133261
work_keys_str_mv AT piperbrianj aquantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks
AT telkuhassenetm aquantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks
AT lambertdrewa aquantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks
AT piperbrianj quantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks
AT telkuhassenetm quantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks
AT lambertdrewa quantitativeanalysisofundisclosedconflictsofinterestinpharmacologytextbooks